Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the adequacy of the support provided to clinicians for post-deployment monitoring of new artificial intelligence tools introduced to local services.

The Government recognises that effective post‑deployment monitoring of artificial intelligence (AI) tools is essential to maintaining patient safety and supporting clinicians in their day‑to‑day practice.

The Government has not conducted a single, centralised assessment of post‑deployment support for all AI tools used in local services. Instead, responsibility for ensuring appropriate monitoring and clinical support sits with local National Health Service organisations, working within national regulatory and governance frameworks.

Nationally, NHS England and the Department have published guidance and regulatory support to help organisations safely deploy and oversee AI technologies. This guidance is currently provided through a combination of regulatory frameworks, clinical safety standards, and product specific national guidance, rather than a single consolidated framework. As set out in the 10-Year Health Plan and the developing AI Strategic Roadmap, the Government is working towards a more coherent, end to end approach to supporting the safe adoption, monitoring, and governance of AI across health and care. This is being done in conjunction with regulators such as the Medicines and Healthcare products Regulation Agency, the National Institute for Health and Care Excellence, the Health Research Authority, and the Care Quality Commission.

Local adopters are expected to ensure that clinicians are supported through appropriate training, access to clinical safety expertise, and clearly defined monitoring arrangements proportionate to the risk and intended use of the AI tool. This includes maintaining oversight of real‑world performance and taking action where tools do not perform as intended.

The Government continues to work closely with NHS England, clinicians, and regulators to keep guidance under review and to identify where further support may be required, as the use of AI in health and care continues to evolve.